Morris H R, Piper P J, Taylor G W, Tippins J R
Br J Pharmacol. 1979 Oct;67(2):179-84. doi: 10.1111/j.1476-5381.1979.tb08664.x.
1 Slow-reacting substance of anaphylaxis (SRS-A) was produced by antigen challenge of passively sensitized human lung and actively sensitized guinea-pig lung. 2 A slow-reacting substance (SRS) was prepared from the peritoneal fluid of rats treated with calcium ionophore A23187. 3 These substances were extensively purified by charcoal adsorption, Sephadex G-15 gel filtration, ether extraction and reverse phase high pressure liquid chromatography. 4 The three substances are pharmacologically, chemically and chromatographically indistinguishable. 5 Our data suggest that the same SRS entities are released from a variety of tissues and that these acidic lipids may have a wider physiological significance than just anaphylaxis.
1 过敏反应迟缓反应物质(SRS-A)是通过对被动致敏的人肺和主动致敏的豚鼠肺进行抗原激发而产生的。2 一种迟缓反应物质(SRS)是从用钙离子载体A23187处理的大鼠腹腔液中制备的。3 这些物质通过活性炭吸附、葡聚糖凝胶G-15凝胶过滤、乙醚萃取和反相高压液相色谱法进行了广泛纯化。4 这三种物质在药理学、化学和色谱方面无法区分。5 我们的数据表明,相同的SRS实体从多种组织中释放出来,并且这些酸性脂质可能具有比过敏反应更广泛的生理意义。